(Total Views: 128)
Posted On: 09/30/2020 8:55:46 AM
Post# of 145362

$ALNY News Article - Alnylam Reports Positive Topline Results from ILLUMINATE-B Phase 3 Study of Lumasiran for the Treatment of Primary Hyperoxaluria Type 1 in Children Under the Age of Six https://marketwirenews.com/news-releases/alny...29351.html


My Twitter: WhyteStocks